Electronic Data Capture Redefined: Challenging the Norm with eSource Innovation

Life Sciences, Pharmaceutical, Healthcare, Digital Health,
  • Thursday, January 30, 2025 | 11:30am EST (NA) / 4:30pm GMT (UK) / 5:30pm CET (EU-Central)
  • 60 min

Over the past 20 years, electronic data capture (EDC) systems have reshaped clinical trials, yet they often fall short of delivering on their promises of speed, efficiency and patient centricity. Despite advancements, the burden on clinical trial sites has only grown.

In response to these challenges, direct data capture (DDC) technologies have emerged, marking a transformative shift in clinical trial execution. DDC is leading to a new era in data collection and management, streamlining the site experience, eliminating paper source documents and enhancing accuracy, efficiency and data integrity.

A single, scalable platform can help in integrating DDC, EDC, electronic clinical outcome assessments (eCOA) and eConsent and can offer remarkable benefits:

  • Enhanced Experience for Site Staff and Participants: The platform can simplify workflows with intuitive interfaces, reducing redundant data entry and making the trial process more seamless for both participants and site teams
  • Immediate, High-Quality Data Collection: By minimizing delays between data capture and analysis, the platform ensures timely access to accurate and reliable trial data, improving overall data quality
  • Real-Time Monitoring: Adaptive trial designs and rapid decision-making can be supported by real-time insights, enabling more responsive and effective trial management

In this webinar, the expert speakers will explore strategies to prioritize site staff experience in technology development. They will discuss how thoughtful innovation can simplify processes and consider what more can be done to revolutionize the clinical trial experience.

Register for this webinar to discover how integrating DDC with EDC, eCOA and eConsent streamlines workflows, enhances data accuracy and improves site and participant experiences.

Speakers

Dermot Kenny, STEM Healthcare

Dermot Kenny, CEO, STEM Healthcare (Moderator)

Dermot Kenny is a seasoned leader with over 25 years of experience in the pharmaceutical and healthcare industries, specializing in clinical operations and biometrics. With extensive global expertise across both CROs and pharmaceutical companies, Dermot has consistently demonstrated a commitment to excellence and innovation in advancing clinical data operations.

At Novartis, Dermot’s visionary leadership redefined the global operating model for data operations, enhancing delivery efficiency and elevating the overall execution experience. Driven by a passion for accelerating clinical trials and ensuring timely access to innovative medicines for patients, Dermot has been at the forefront of transformative initiatives in the sector.

As CEO of STEM Healthcare, Dermot has pivoted to transforming the commercialization of innovative medicines, helping to ensure optimized returns on investment for stakeholders. His diverse background and strategic acumen continue to leave a lasting impact across the pharmaceutical and healthcare landscape.

Message Presenter
Megan Petrylak, Clinical ink

Megan Petrylak, Chief Operating Officer, Clinical ink

With over 17 years of clinical trial experience, including 14 years in operational leadership roles, Megan Petrylak plays a key role at Clinical ink. She oversees all customer, site and patient-facing operations, enhancing Clinical ink’s capabilities in data management and quality assurance. Her commitment to fostering a quality-first culture has led to remarkable improvements in customer satisfaction, reduced study build and execution times and outstanding quality outcomes.

Megan has a proven track record in driving successful Phase I-III clinical trials for a diverse range of global biopharmaceutical companies and contract research organizations (CROs). Before joining Clinical ink in 2018, she served as Director of Project Delivery at Worldwide Clinical Trials and previously led Bioclinica’s eClinical project management and support services.

Beyond her extensive expertise in eCOA, project management and data management, Megan is a dedicated team builder who believes that exceptional customer satisfaction begins with nurturing and supporting employees.

Message Presenter

Who Should Attend?

This webinar will appeal to:

  • Medium-to-Large Pharma and CROs
  • Director/VP/Head of Clinical Operations
  • Diabetes/Cardiometabolic Therapeutic Head/Lead
  • Chief Medical Director
  • Director/VP/Head of Digital Innovation/Engagement

What You Will Learn

Attendees will learn about:

  • How DDC represents a transformative step in clinical trials, addressing inefficiencies in traditional EDC systems
  • How a single platform that integrates DDC, EDC, eCOA and eConsent can simplify workflows, minimize redundant data entry and improve the experience for site staff and participants
  • How innovations in clinical’trial technology should focus on streamlining processes for site staff and participants

Xtalks Partner

Clinical ink

Clinical ink is a global life science company bringing data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, behavioral and dropout prediction, eConsent, telehealth, and digital biomarkers advancements (including use of Continuous Glucose Monitoring for detection of hypoglycemia), support the next generation of clinical trials and ultimately the clinical management of patients.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account